ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Revenue

ACADIA Pharmaceuticals had revenue of $264.57M in the quarter ending June 30, 2025, with 9.34% growth. This brings the company's revenue in the last twelve months to $1.02B, up 14.41% year-over-year. In the year 2024, ACADIA Pharmaceuticals had annual revenue of $957.80M with 31.85% growth.

• Revenue (ttm): $1.02B
• Revenue Growth: +14.41%
• P/S Ratio: 4.14
• Revenue / Employee: $1,557,928
• Employees: 654
• Market Cap: 4.26B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	957.80M	231.36M	31.85%
Dec 31, 2023	726.44M	209.20M	40.45%
Dec 31, 2022	517.24M	33.09M	6.83%
Dec 31, 2021	484.15M	42.39M	9.60%
Dec 31, 2020	441.76M	102.68M	30.28%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.